Should you buy Cresco Labs stock? (OTC:CRLBF). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages | Neutral |
---|---|---|
|
|
|
CRLBF Price (Cresco Labs stock price per share) |
$2.60 | |
PE Ratio versus Sector | 100% lower than other Healthcare stocks | |
PE Ratio versus Industry | 0% lower than other Drug Manufacturers - Specialty & Generic stocks | |
Free Cash Flow Jitter | 0% |
Based on our analysis, we believe that you should not buy Cresco Labs right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Does Cresco Labs have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles
Rethinking Loss in the Stock Market
What is Dollar Cost Averaging?
Should You Invest in Gold or Silver?
What Does the Efficient Market Hypothesis Mean for Value Investors?